Takao Fujisawa Selected Research

Procaterol (Pro-Air)

1/2017	β2 adrenergic agonist suppresses eosinophil-induced epithelial-to-mesenchymal transition of bronchial epithelial cells.
1/2011	Inhibition of eosinophil activation mediated by a Toll-like receptor 7 ligand with a combination of procaterol and budesonide.
2/2002	Synergistic effect of theophylline and procaterol on interleukin-5-induced degranulation from human eosinophils.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takao Fujisawa Research Topics

Disease

36	Asthma (Bronchial Asthma) 04/2022 - 02/2002
18	Inflammation (Inflammations) 01/2022 - 02/2002
16	Hypersensitivity (Allergy) 01/2022 - 11/2009
7	Neoplasms (Cancer) 01/2022 - 10/2016
7	Atopic Dermatitis (Atopic Eczema) 10/2021 - 07/2002
6	Allergic Rhinitis 01/2020 - 01/2008
5	Respiratory Sounds (Crackle) 01/2022 - 11/2009
5	Anaphylaxis (Anaphylactic Shock) 01/2021 - 02/2013
5	Food Hypersensitivity (Food Allergy) 01/2020 - 01/2012
5	Airway Remodeling 01/2018 - 01/2005
5	Seasonal Allergic Rhinitis (Hay Fever) 06/2014 - 01/2008
4	Egg Hypersensitivity (Egg Allergy) 10/2021 - 01/2016
4	Squamous Cell Carcinoma of Head and Neck 10/2021 - 01/2018
4	Bronchiolitis 05/2013 - 05/2010
3	Wheat Hypersensitivity (Wheat Allergy) 01/2021 - 06/2009
3	Pneumococcal Infections 11/2020 - 01/2018
3	Infections 03/2020 - 09/2012
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 11/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 10/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2020
2	Drug Hypersensitivity (Drug Allergy) 10/2020 - 01/2020
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2020 - 12/2017
2	Nasopharyngeal Carcinoma 01/2020 - 12/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 12/2017
2	Malnutrition (Nutritional Deficiencies) 01/2019 - 02/2016
2	Pneumonia (Pneumonitis) 01/2019 - 02/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 06/2016 - 05/2010
2	Bronchiectasis 06/2016 - 07/2010
2	Human Influenza (Influenza) 02/2016 - 09/2012
2	Eosinophilia 01/2012 - 01/2011
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 04/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Pre-Eclampsia (Preeclampsia) 11/2021
1	Hypoxia (Hypoxemia) 11/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2021
1	COVID-19 09/2021

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
12	Immunoglobulin E (IgE)IBA 01/2022 - 09/2008
11	CytokinesIBA 01/2019 - 01/2005
9	AllergensIBA 04/2022 - 01/2008
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2022 - 07/2010
6	Eosinophil-Derived NeurotoxinIBA 11/2019 - 05/2010
5	Pharmaceutical PreparationsIBA 04/2022 - 10/2016
5	Cetuximab (Erbitux)FDA Link 10/2021 - 01/2018
5	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2020 - 07/2010
5	Interleukin-5 (Interleukin 5)IBA 04/2012 - 02/2002
4	PlatinumIBA 01/2022 - 01/2018
4	VaccinesIBA 11/2020 - 03/2016
4	montelukast (Singulair)FDA Link 11/2018 - 05/2010
4	ChemokinesIBA 07/2017 - 07/2002
4	tulobuterolIBA 03/2013 - 05/2012
3	AntigensIBA 10/2021 - 06/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2008
3	Procaterol (Pro-Air)IBA 01/2017 - 02/2002
3	AntibodiesIBA 01/2017 - 01/2011
3	Catechin (Z 7300)IBA 06/2014 - 09/2009
3	TeaIBA 06/2014 - 09/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2014 - 01/2008
2	NivolumabIBA 01/2022 - 01/2020
2	COVID-19 VaccinesIBA 01/2021 - 01/2021
2	Conjugate VaccinesIBA 11/2020 - 01/2018
2	Contrast MediaIBA 10/2020 - 01/2020
2	Tacrolimus (Prograf)FDA LinkGeneric 07/2020 - 12/2019
2	Ointments (Pastes)IBA 07/2020 - 12/2019
2	EmollientsIBA 07/2020 - 12/2019
2	Superoxide Dismutase-1IBA 01/2020 - 10/2015
2	Gemcitabine FDA Link 01/2020 - 12/2017
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 01/2020
2	Budesonide (Pulmicort)FDA LinkGeneric 11/2018 - 01/2011
2	Interleukin-10 (Interleukin 10)IBA 01/2018 - 01/2012
2	Peptide Hydrolases (Proteases)FDA Link 07/2017 - 01/2008
2	Omalizumab (Xolair)FDA Link 01/2017 - 10/2015
2	Salmeterol Xinafoate (Serevent)FDA Link 07/2016 - 07/2010
2	Fluticasone (Cutivate)FDA LinkGeneric 07/2016 - 10/2015
2	gallocatechol (epigallocatechin)IBA 06/2014 - 01/2014
2	methyl gallateIBA 06/2014 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2014 - 08/2005
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 03/2013 - 01/2013
2	Superoxides (Superoxide)IBA 01/2013 - 01/2008
2	InterleukinsIBA 04/2012 - 02/2002
2	LigandsIBA 01/2011 - 07/2002
2	Chemokine CCL17IBA 11/2009 - 07/2002
2	SmokeIBA 11/2009 - 08/2005
1	GlobulinsIBA 01/2022
1	Histones (Histone)IBA 11/2021
1	Histone MethyltransferasesIBA 11/2021
1	squamous cell carcinoma-related antigenIBA 10/2021
1	Coloring Agents (Dyes)IBA 10/2021
1	dupilumabIBA 10/2020

Therapy/Procedure

16	Therapeutics 01/2022 - 06/2009
8	Immunotherapy 04/2022 - 01/2008
3	Drug Therapy (Chemotherapy) 01/2020 - 12/2017
3	Complementary Therapies (Alternative Medicine) 06/2014 - 01/2012
2	Precision Medicine 01/2022 - 11/2021
2	Aftercare (After-Treatment) 07/2020 - 01/2018
2	Oral Administration 01/2020 - 01/2011
2	Chemoradiotherapy 01/2020 - 01/2018
1	Nebulizers and Vaporizers (Inhaler) 09/2021